Researchers found that diabetes patients with all three risk factors (AKI, proteinuria, and poor blood sugar control) lose renal function at nearly 5% annually, accelerating dialysis need to within 12 years. Patients with two or one of these risk factors still face accelerated loss of renal function.
A study found that intensive systolic blood pressure lowering can prolong life compared to standard levels, preventing approximately 107,500 deaths per year. Additionally, this approach is projected to save around 32,800 lives annually among adults with stage 3-4 chronic kidney disease.
Researchers have developed a living membrane using conditionally immortalized human renal proximal tubular epithelial cells on polyethersulfone-based hollow fiber membranes. This breakthrough brings the development of a bioartificial kidney closer to reality, offering hope for millions of patients with kidney failure.
Recent studies have yielded promising results for patients with type 2 diabetes, including a 21% reduced risk of kidney dysfunction or death. Remote ischemic preconditioning has also shown sustained improvement in kidney function after transplantation. Meanwhile, trials examining dialysate sodium levels and voclosporin treatment have o...
Research found that short and poor quality sleep were associated with a lower risk of developing kidney failure, while higher sleep fragmentation increased the risk. Patients who experienced daytime sleepiness also had a higher risk of death during follow-up.
A study by Eugene Lin and colleagues found that multi-disciplinary care is a cost-effective intervention, costing $24,613 per quality-adjusted life year (QALY), compared to dialysis which costs $129,090 per QALY. This approach can improve the health of patients with kidney disease while reducing medical costs.